De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
FINDEX Inkomsten in het verleden
Verleden criteriumcontroles 6/6
FINDEX has been growing earnings at an average annual rate of 17.3%, while the Healthcare Services industry saw earnings growing at 17.3% annually. Revenues have been growing at an average rate of 5.3% per year. FINDEX's return on equity is 27.6%, and it has net margins of 24%.
Belangrijke informatie
17.3%
Groei van de winst
17.3%
Groei van de winst per aandeel
| Healthcare Services Groei van de industrie | 19.2% |
| Inkomstengroei | 5.3% |
| Rendement op eigen vermogen | 27.6% |
| Nettomarge | 24.0% |
| Volgende winstupdate | 13 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
FINDEX Inc.'s (TSE:3649) Popularity With Investors Is Under Threat From Overpricing
Sep 05
FINDEX (TSE:3649) Will Pay A Dividend Of ¥7.00
Jun 07FINDEX (TSE:3649) Is Due To Pay A Dividend Of ¥7.00
Apr 25FINDEX (TSE:3649) Is Due To Pay A Dividend Of ¥7.00
Apr 11After Leaping 29% FINDEX Inc. (TSE:3649) Shares Are Not Flying Under The Radar
Mar 10Opbrengsten en kosten
Hoe FINDEX geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 6,147 | 1,477 | 1,931 | 0 |
| 31 Mar 24 | 6,064 | 1,502 | 1,885 | 0 |
| 31 Dec 23 | 5,191 | 1,059 | 1,832 | 0 |
| 30 Sep 23 | 5,016 | 940 | 1,766 | 0 |
| 30 Jun 23 | 4,557 | 686 | 1,706 | 0 |
| 31 Mar 23 | 4,528 | 663 | 1,700 | 0 |
| 31 Dec 22 | 4,541 | 722 | 1,694 | 0 |
| 30 Sep 22 | 4,454 | 500 | 1,681 | 0 |
| 30 Jun 22 | 4,796 | 615 | 1,685 | 0 |
| 31 Mar 22 | 4,770 | 580 | 1,656 | 0 |
| 31 Dec 21 | 4,968 | 636 | 1,635 | 0 |
| 30 Sep 21 | 4,550 | 573 | 1,593 | 0 |
| 30 Jun 21 | 4,149 | 395 | 1,554 | 0 |
| 31 Mar 21 | 3,836 | 297 | 1,483 | 0 |
| 31 Dec 20 | 4,004 | 430 | 1,483 | 0 |
| 30 Sep 20 | 3,697 | 246 | 1,532 | 0 |
| 30 Jun 20 | 4,620 | 689 | 1,559 | 0 |
| 31 Mar 20 | 4,741 | 751 | 1,621 | 0 |
| 31 Dec 19 | 4,281 | 499 | 1,587 | 0 |
| 30 Sep 19 | 5,129 | 1,035 | 1,560 | 0 |
| 30 Jun 19 | 4,072 | 548 | 1,510 | 0 |
| 31 Mar 19 | 3,839 | 467 | 1,429 | 0 |
| 31 Dec 18 | 3,603 | 398 | 1,400 | 0 |
| 30 Sep 18 | 3,166 | 174 | 1,336 | 0 |
| 30 Jun 18 | 3,255 | 255 | 1,356 | 0 |
| 31 Mar 18 | 3,519 | 422 | 1,376 | 0 |
| 31 Dec 17 | 3,311 | 366 | 1,347 | 0 |
Kwaliteitswinsten: 3649 has high quality earnings.
Groeiende winstmarge: 3649's current net profit margins (24%) are higher than last year (15.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 3649's earnings have grown by 17.3% per year over the past 5 years.
Versnelling van de groei: 3649's earnings growth over the past year (115.3%) exceeds its 5-year average (17.3% per year).
Winst versus industrie: 3649 earnings growth over the past year (115.3%) exceeded the Healthcare Services industry 11.9%.
Rendement op eigen vermogen
Hoge ROE: 3649's Return on Equity (27.6%) is considered high.